Clinical Trials Browser

Phase 1/2 × OTHER × Advanced Colorectal Cancer × Clear all

NCT05035914 2021-09-05

Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Advanced Colorectal Cancer

NCT04929652 2021-06-18

Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Advanced Colorectal Cancer